GMP IPO Watch
WhiteOak Capital Quality Equity Fund
Regular Plan · Growth Option · WhiteOak Capital Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +4.54% | +3.52% | 60 of 255 |
| 1M | +3.90% | +1.97% | 53 of 255 |
| 3M | -5.73% | -3.45% | 186 of 252 |
| 6M | +2.79% | +2.92% | 97 of 251 |
| YTD | -6.00% | +1.21% | 187 of 255 |
| 1Y | -5.47% | +1.11% | 155 of 232 |
| INCEPTION | -0.05% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +0.85% | +13.96% | -15.89% | 60% | 23% |
| 6M | -0.01% | +12.33% | -14.76% | 56% | 21% |
| 1Y | -3.14% | +4.81% | -11.17% | 23% | 7% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity90.48%
- Debt3.89%
- Cash5.63%
- Other0.00%
Market Cap Split
- Large Cap51.99%
- Mid Cap15.72%
- Small Cap22.77%
- Others9.52%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 32.23 | 27.94 |
| P/B | 4.89 | 4.57 |
| Price / Sales | 4.57 | 3.25 |
| Price / Cash Flow | 24.67 | 20.95 |
| Dividend Yield (%) | 1.26 | 1.18 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| ICICI Bank | Banks | 9.82% | — |
| Nestle | Food Products | 6.67% | — |
| Bharti Airtel | Telecom - Services | 6.10% | — |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 4.27% | — |
| Clearing Corporation of India Ltd | Net Current Assets | 4.17% | — |
| Mahindra & Mahindra | Automobiles | 4.16% | — |
| Titan | Consumer Durables | 3.78% | — |
| Nexus Select Trust REIT | Realty | 3.41% | — |
| Maruti Suzuki | Automobiles | 2.70% | — |
| Eternal | Retailing | 2.63% | — |
| Info Edge | Retailing | 2.55% | — |
| Marico | Agricultural Food & other Products | 2.42% | — |
| Pidilite Industries | Chemicals & Petrochemicals | 2.27% | — |
| Global Health | Equity | 2.25% | — |
| Persistent Systems | IT - Software | 2.08% | — |
View all 63 holdings
| Muthoot Finance | Finance | 1.49% | — |
| SBI Funds Management | Capital Markets | 1.48% | — |
| Aadhar Housing Finance | Finance | 1.48% | — |
| Abbott | Pharmaceuticals & Biotechnology | 1.47% | — |
| Net Receivables / (Payables) | Net Current Assets | 1.46% | — |
| DOMS Industries | Household Products | 1.45% | — |
| Poly Medicure | Equity | 1.28% | — |
| Tata Consumer Products | Agricultural Food & other Products | 1.28% | — |
| Asian Paints | Consumer Durables | 1.26% | — |
| Gillette | Personal Products | 1.25% | — |
| CARE Ratings | Capital Markets | 1.23% | — |
| Krishna Institute of Medical Sciences | Equity | 1.23% | — |
| Tata Consultancy Services | IT - Software | 1.23% | — |
| Rainbow Childrens Medicare | Equity | 1.21% | — |
| Embassy Office Parks REIT | Realty | 1.17% | — |
| Cipla | Pharmaceuticals & Biotechnology | 1.15% | — |
| Eureka Forbes | Consumer Durables | 1.13% | — |
| Navin Fluorine International | Chemicals & Petrochemicals | 1.05% | — |
| India Shelter Finance | Finance | 1.05% | — |
| Ajax Engineering | Agricultural, Commercial & Construction Vehicles | 1.02% | — |
| Indigo Paints | Consumer Durables | 0.99% | — |
| Max Financial Services | Insurance | 0.97% | — |
| Tech Mahindra | IT - Software | 0.96% | — |
| Leela Palaces Hotels & Resorts | Leisure Services | 0.94% | — |
| Phoenix Mills | Realty | 0.92% | — |
| Tube Investment | Auto Components | 0.89% | — |
| Bajaj Finserv | Finance | 0.86% | — |
| Vijaya Diagnostic Centre | Equity | 0.81% | — |
| Hindustan Unilever | Diversified FMCG | 0.78% | — |
| 91 Days Tbill (MD 08/10/2026) | Money Market | 0.72% | — |
| Safari Industries | Consumer Durables | 0.69% | — |
| 91TB051126 | Money Market | 0.65% | — |
| Colgate Palmolive | Personal Products | 0.62% | — |
| 91TB221026 | Money Market | 0.58% | — |
| 182TB51126 | Money Market | 0.52% | — |
| Vishal Mega Mart | Retailing | 0.50% | — |
| 182T121126 | Money Market | 0.48% | — |
| P&G Hygiene and Health Care | Personal Products | 0.45% | — |
| National Stock Exchange of India | Capital Markets | 0.40% | — |
| 91TB191126 | Money Market | 0.36% | — |
| 91TB291026 | Money Market | 0.32% | — |
| Newgen Software Technologies | IT - Software | 0.30% | — |
| Coforge | IT - Software | 0.19% | — |
| Infosys | IT - Software | 0.17% | — |
| 364T121126 | Money Market | 0.13% | — |
| 91TB031226 | Money Market | 0.13% | — |
| LTM | IT - Software | 0.01% | — |
| Max Healthcare Institute | Equity | 0.01% | — |
Sector Allocation · Sep 2026
View all 22 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 12.45 | 16.32 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.79 | -0.32 | Below Average |
| 3Y | -0.46 | -0.45 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.54 | 0.19 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+59.64% | +47.37% | — | +23.17% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+25.51% | +31.04% | — | +30.18% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+23.57% | — | — | +20.10% |
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+22.37% | — | — | +11.34% |
|
Mirae Asset Healthcare Fund
Direct Plan · Growth
|
+21.28% | +24.36% | +16.89% | +22.00% |
|
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
|
+20.32% | +18.33% | +12.09% | +15.77% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+20.03% | — | — | +11.89% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+18.89% | +19.86% | +8.28% | +8.45% |
|
HDFC Defence Fund
Regular Plan · IDCW Option
|
+18.80% | +34.56% | — | +36.67% |
|
HSBC India Export Opportunities Fund
Direct Plan · Growth
|
+18.74% | — | — | +9.24% |
More From WhiteOak Capital Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
WhiteOak Capital Pharma and Healthcare Fund
Direct Plan · Growth Option
|
+20.63% | — | — | +22.86% |
|
WhiteOak Capital Special Opportunities Fund
Direct Plan · Growth Option
|
+9.86% | — | — | +16.53% |
|
WhiteOak Capital Arbitrage Fund
Direct Plan · Growth Option
|
+7.12% | — | — | +7.24% |
|
WhiteOak Capital Multi Asset Allocation Fund
Direct Plan · Growth Option
|
+6.82% | +16.01% | — | +15.30% |
|
WhiteOak Capital Mid Cap Fund
Direct Plan · Growth Option
|
+6.44% | +20.80% | — | +21.53% |
|
WhiteOak Capital Liquid Fund
Direct Plan · Growth Option
|
+6.39% | +6.80% | +6.26% | +5.63% |
|
WhiteOak Capital Ultra Short Term Fund
Direct Plan · Growth Option
|
+6.24% | +6.93% | +6.37% | +5.90% |
|
WhiteOak Capital Equity Savings Fund
Direct Plan · Growth Option
|
+5.27% | — | — | +10.73% |
|
WhiteOak Capital Multi Cap Fund
Direct Plan · Growth Option
|
+2.50% | +18.14% | — | +17.57% |
|
WhiteOak Capital Balanced Advantage Fund
Direct Plan · Growth Option
|
+1.98% | +11.98% | — | +12.76% |
About This Scheme
Investment Objective
The objective of the Scheme is to provide long term capital appreciation by constructing a diversified investment portfolio based on the quality factor theme to provide investors with exposure to companies having strong fundamentals and sustainable competitive advantages, i.e., companies which exhibit long term stability as they may lead to more predictable returns, less volatility, strong management and sustainable growth. There is no assurance that the investment objective of the Scheme will be achieved
Stated Asset Allocation
Equity & Equity related Instruments of companies following Quality Factor theme (including REITs): 80% - 100%; Equity & Equity related Instruments of companies other than above (including REITs): 0% - 20%; Money Market Instruments#, Other Liquid Instruments^, Gold and Silver ETFs and units of Domestic Mutual Fund Schemes@: 0% - 20%; Units issued by InvITs: 0% - 10% # Money market instruments include commercial papers, commercial bills, treasury bills, Government securities having an unexpired maturity up to one year, call or notice money, certificate of deposit, usance bills, and any other like instruments as specified by the Reserve Bank of India. ^Other liquid instruments shall include cash, bank deposits with Scheduled Commercial Banks, Government Securities, Treasury bills, Repo on Government securities and any other instruments as specified by SEBI. @Units of domestic mutual fund schemes are permitted only in Overnight funds, Liquid funds and Money Market funds. As per Para 3.8.1.c of SEBI Master Circular on Mutual Funds dated March 20, 2026, the Scheme will invest residual portion in equity and equity related instruments, money market instruments and other liquid instruments, gold and silver instruments (ETFs) as permitted by SEBI and in InvITs, subject to the ceilings laid out in SEBI (Mutual Fund) Regulations, 2026 with respect to the respective asset class.
Exit Load
Nil
Fund Managers
FM1 - Mr. Ramesh Mantri; FM2- Mr. Piyush Baranwal; FM3 - Ms. Trupti Agrawal; FM4 - Mr. Dheeresh Pathak; FM5 - Mr. Ashish Agrawal
FM1 - Comanage/Equity; FM2 - Comanage/Debt; FM3 - Assistant Fund Manager - Equity; FM4 - Assistant Fund Manager - Equity; FM5 - Fund Manager - Arbitrage Transactions
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.